Andere talen Clover Biopharmaceuticals, Ltd.

Aandelen

2197

KYG2280A1076

Beurs gesloten - Hong Kong S.E. Andere beurzen 10:08:20 16-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,33 ^HKD	-5,71%		-16,46%	-46,77%

08/04	De RSV-vaccinkandidaat van Clover Biopharmaceuticals toont veelbelovend in een vroeg onderzoek	MT
08/04	Clover Biopharmaceuticals, Ltd. kondigt positieve voorlopige Fase I resultaten aan voor bivalent RSV-vaccin SCB-1019 in het eerste cohort van jongvolwassenen	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Clover Biopharmaceuticals, Ltd. announced that it has received $0.320713 million in funding	12/04
Clover Biopharmaceuticals' RSV Vaccine Candidate Shows Promise in Early Trial	08/04
Clover Announces Positive Preliminary Phase I Results for Bivalent RSV Vaccine Candidate SCB-1019 in Initial Young Adult Cohort	08/04
Clover Biopharmaceuticals, Ltd. Announces Positive Preliminary Phase I Results for Bivalent RSV Vaccine Candidate SCB-1019 In Initial Young Adult Cohort	08/04
Clover Biopharmaceuticals, Ltd. announced that it expects to receive $0.320713 million in funding	02/04
Clover Biopharmaceuticals Trims Losses in 2023	27/03
Clover Biopharmaceuticals, Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	26/03
Sinovac Halts Production of COVID-19 Vaccine as Demand Wanes	12/01
Clover Announces Positive Phase ? Results for SCB-219M for Treatment of Chemotherapy-Induced Thrombocytopenia (CIT)	29/12
Clover Biopharmaceuticals Publishes Positive Results from SCB-219M Clinical Trial	29/12
Clover Biopharmaceuticals, Ltd. Announces Positive Phase I Results for SCB-219M for Treatment of Chemotherapy-Induced Thrombocytopenia	29/12
Clover Biopharmaceuticals Completes Patient Enrollment for Australia Phase 1 Trial; Shares Fall 5%	13/12
Clover Initiates Phase Ⅰ Clinical Trial for RSV Vaccine Candidate	13/12
Clover Biopharmaceuticals, Ltd. Initiates Phase Clinical Trial for RSV Vaccine Candidate	13/12
Clover Biopharmaceuticals Completes Submission of Application for Seasonal Flu Vaccine in Brazil	07/11
Clover Biopharmaceuticals, Ltd. Completes Biologic License Application for Its Seasonal Influenza Vaccine in Brazil	07/11
Clover Biopharmaceuticals Rolls Out Quadrivalent Seasonal Influenza Vaccine in Mainland China	12-09-23
Clover Launches Quadrivalent Seasonal Influenza Vaccine in Mainland China	12-09-23
Clover Launches Quadrivalent Seasonal Influenza Vaccine in Mainland China	12-09-23
Clover Launches Quadrivalent Seasonal Influenza Vaccine in Mainland China	12-09-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Clover Biopharmaceuticals, Ltd.

Aandelen

2197

KYG2280A1076

Andere talen

Filters